Ethic Inc’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $703K | Buy |
2,176
+133
| +7% | +$42.9K | 0.01% | 720 |
|
|
2025
Q1 | $523K | Sell |
2,043
-2,843
| -58% | -$727K | 0.01% | 775 |
|
|
2024
Q4 | $1.15M | Buy |
4,886
+910
| +23% | +$214K | 0.02% | 555 |
|
|
2024
Q3 | $594K | Buy |
3,976
+449
| +13% | +$67.1K | 0.02% | 723 |
|
|
2024
Q2 | $857K | Sell |
3,527
-449
| -11% | -$109K | 0.02% | 612 |
|
|
2024
Q1 | $594K | Sell |
3,976
-33
| -0.8% | -$4.93K | 0.02% | 721 |
|
|
2023
Q4 | $767K | Buy |
4,009
+337
| +9% | +$64.5K | 0.02% | 615 |
|
|
2023
Q3 | $650K | Buy |
3,672
+1,699
| +86% | +$301K | 0.02% | 596 |
|
|
2023
Q2 | $375K | Buy |
1,973
+455
| +30% | +$86.4K | 0.01% | 734 |
|
|
2023
Q1 | $304K | Sell |
1,518
-391
| -20% | -$78.3K | 0.01% | 785 |
|
|
2022
Q4 | $454K | Buy |
1,909
+217
| +13% | +$51.6K | 0.02% | 602 |
|
|
2022
Q3 | $339K | Buy |
1,692
+172
| +11% | +$34.5K | 0.02% | 605 |
|
|
2022
Q2 | $222K | Buy |
+1,520
| New | +$222K | 0.02% | 694 |
|
|
2021
Q4 | – | Sell |
-1,122
| Closed | -$212K | – | 665 |
|
|
2021
Q3 | $212K | Buy |
+1,122
| New | +$212K | 0.02% | 568 |
|